A detailed history of Wellington Management Group LLP transactions in Hille Vax, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 62,817 shares of HLVX stock, worth $128,774. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,817
Previous 68,052 7.69%
Holding current value
$128,774
Previous $984,000 88.82%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.58 - $14.42 $8,271 - $75,488
-5,235 Reduced 7.69%
62,817 $110,000
Q2 2024

Aug 13, 2024

BUY
$11.86 - $15.93 $72,689 - $97,634
6,129 Added 9.9%
68,052 $984,000
Q1 2024

May 15, 2024

BUY
$14.15 - $19.75 $876,210 - $1.22 Million
61,923 New
61,923 $1.03 Million

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $68.5M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.